P68 Cost-Effectiveness of Ofatumumab in Comparison with Teriflunomide for Relapsing Multiple Sclerosis Treatment in China: From Both Healthcare System and Societal Perspectives

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.087
https://www.valueinhealthjournal.com/article/S1098-3015(22)00288-1/fulltext
Title : P68 Cost-Effectiveness of Ofatumumab in Comparison with Teriflunomide for Relapsing Multiple Sclerosis Treatment in China: From Both Healthcare System and Societal Perspectives
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00288-1&doi=10.1016/j.jval.2022.04.087
First page :
Section Title :
Open access? : No
Section Order : 10074
Categories :
Tags :
Regions :
ViH Article Tags :